Literature DB >> 12050215

AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype.

Maria Halonen1, Petra Eskelin, Anne-Grethe Myhre, Jaakko Perheentupa, Eystein S Husebye, Olle Kämpe, Fredrik Rorsman, Leena Peltonen, Ismo Ulmanen, Jukka Partanen.   

Abstract

Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, OMIM 240300) is a rare autoimmune disease caused by mutations in the autoimmune regulator (AIRE) gene on chromosome 21q22.3. This monogenic disease provides an interesting model for studies of other common and more complex autoimmune diseases. The most common components of APECED are chronic mucocutaneous candidiasis, hypoparathyroidism, and Addison's disease, but several other endocrine deficiencies and ectodermal dystrophies also occur and the phenotype varies widely. The AIRE genotype also varies; 42 different mutations have been reported so far. To understand the complexity of the phenotype, we studied the AIRE and human leukocyte antigen (HLA) class II genotypes in a series of patients with APECED. The only association between the phenotype and the AIRE genotype was the higher prevalence of candidiasis in the patients with the most common mutation, R257X, than in those with other mutations. Addison's disease was associated with HLA-DRB1*03 (P = 0.021), alopecia with HLA-DRB1*04- DQB1*0302 (P < 0.001), whereas type 1 diabetes correlated negatively with HLA-DRB1*15-DQB1*0602 (P = 0.036). The same HLA associations have previously been established for non-APECED patients. We conclude that mutation of AIRE per se has little influence on the APECED phenotype, whereas, in contrast to earlier reports, HLA class II is a significant determinant.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12050215     DOI: 10.1210/jcem.87.6.8564

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  38 in total

Review 1.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

2.  High intrafamilial variability in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: a case study.

Authors:  D Capalbo; A Fusco; G Aloj; N Improda; L Vitiello; U Dianzani; C Betterle; M Salerno; C Pignata
Journal:  J Endocrinol Invest       Date:  2011-11-07       Impact factor: 4.256

Review 3.  Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunity.

Authors:  P Peterson; J Pitkänen; N Sillanpää; K Krohn
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

4.  Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Authors:  Choudhary Sonal; McLeod Michael; Torchia Daniele; Romanelli Paolo
Journal:  J Clin Aesthet Dermatol       Date:  2012-12

Review 5.  Polyendocrine autoimmunity.

Authors:  Jennifer M Barker
Journal:  Curr Diab Rep       Date:  2005-04       Impact factor: 4.810

Review 6.  Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy.

Authors:  Kai Kisand; Pärt Peterson
Journal:  J Clin Immunol       Date:  2015-07-05       Impact factor: 8.317

Review 7.  Polyglandular autoimmune syndromes.

Authors:  G J Kahaly; L Frommer
Journal:  J Endocrinol Invest       Date:  2017-08-17       Impact factor: 4.256

8.  Aire is not essential for regulating neuroinflammatory disease in mice transgenic for human autoimmune-diseases associated MHC class II genes HLA-DR2b and HLA-DR4.

Authors:  Saisha A Nalawade; Niannian Ji; Itay Raphael; Andrew Pratt; Ellen Kraig; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2018-05-14       Impact factor: 4.868

9.  A multidisciplinary approach to management of autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED).

Authors:  Mohammed Ramzy Gouda; Azzam Al-Amin; Heike Grabsch; Clare Donnellan
Journal:  BMJ Case Rep       Date:  2013-01-30

Review 10.  Immune deficiency disorders with autoimmunity and abnormalities in immune regulation-monogenic autoimmune diseases.

Authors:  Heather K Lehman; Mark Ballow
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.